Streamlining clinical trials, harmonising regulations and improving access to capital should be driving biotech efforts, ...

Vishnu Tripathi develops reagents and assays to advance clinical care and research diagnostics.

So, what will the early months of 2026 look like for the biotech sector? First, let me say that the biotech sector being 'en fuego' over the past three quarters has made my year as far as my portfolio ...

Dr. Frank Bedu-Addo has served as President, CEO and a director of PDS Biotechnology Corporation since its inception in 2005. Dr. Bedu-Addo is a veteran biotech executive with experience successfully ...

Biotechnology stocks are wrapping up 2025 on a high note, bouncing back from a rocky start to deliver some of the year’s most impressive gains. What began as a sector weighed down by tariff fears and ...

Every year, thousands of biotech breakthroughs stall. Not because the science failed, but because the story did. A survey of biotech investors found that 86% believe that fewer than half of management ...

The European Union’s upcoming Biotech Act is hotly anticipated in the world of food. The Act could be integral to food innovation, streamlining regulation in areas such as precision fermentation. The ...